Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial-Reference-Cited by-同舟云学术

Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial

Published:2018-01 Issue:1 Volume:55 Page:109-117
ISSN:1078-5884
Container-title:European Journal of Vascular and Endovascular Surgery
language:en
Short-container-title:European Journal of Vascular and Endovascular Surgery

Author:

Norgren Lars,Patel Manesh R.,Hiatt William R.,Wojdyla Daniel M.,Fowkes F. Gerry R.,Baumgartner Iris,Mahaffey Kenneth W.,Berger Jeffrey S.,Jones W. Schuyler,Katona Brian G.,Held Peter,Blomster Juuso I.,Rockhold Frank W.,Björck Martin^ORCID

Funder

AstraZeneca

Bayer

AnGes MG

Pluristem Therapeutics

Cesca Therapeutics

Mitsubishi Tanabe Pharma

CSI

Genzyme

Janssen Research & Development

Medtronic

Merck

HeartFlow

Maquet

NHLBI

Jansen

Pluristem

Sanofi

Abbott Vascular

Cook Medical

Optimed

Terumo Medical

Promedics

Amgen

Boston Scientific

BAROnova

Bio2 Medical

Boehringer Ingelheim

Bristol-Myers Squibb

Cubist

Eli Lilly

Epson

Forest Laboratories

GlaxoSmithKline

Johnson & Johnson

MyoKardia

Omthera Pharmaceuticals

Portola Pharmaceuticals

Purdue Pharma

Medicines Company

Theravance

Vindico

WebMD

Daiichi-Sankyo

St. Jude Medical

Tenax Therapeutics

Janssen

Takeda

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference29 articles.

1. Inter-society consensus for the management of peripheral arterial disease (TASC II);Norgren;Eur J Vasc Endovasc Surg,2007

2. ACC/AHA Guidelines for the management of patients with peripheral arterial disease;Hirsch;J Am Coll Cardiol,2006

3. Epidemiology of peripheral arterial disease and critical limb ischaemia in an insured national population;Nehler;J Vasc Surg,2014

4. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia;Belch;Lancet,2011

5. The importance of early diagnosis and treatment in peripheral arterial disease: insights from the PARTNERS and REACH registries;Mukherjee;Curr Vasc Pharmacol,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases;European Journal of Vascular and Endovascular Surgery;2023-05

2. Mesenchymal stem cells in ischemic tissue regeneration;World Journal of Stem Cells;2023-02-26

3. Early experience with venous arterialization for limb salvage in no-option patients with chronic limb-threatening ischemia;Journal of Vascular Surgery;2022-10

4. Impact of Modified H<sub>2</sub>FPEF Score on Chronic Limb-Threatening Ischemia in Patients With Lower Extremity Artery Disease Who Underwent Endovascular Therapy;Circulation Reports;2022-08-10

5. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28